EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Epidemiological and Molecular Surveillance of Multiresistant Citrobacter freundii Complex in a Tertiary Care Hospital: A Retrospective Cohort Study

Pérince Fonton, Roberto Sierra, Romain Martischang iD, Aude Nguyen, Abdessalam Cherkaoui, Diego O Andrey iD, Stephan Harbarth iD

The Journal of Infectious Diseases · 2026

DOI: 10.1093/infdis/jiag066 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Pérince Fonton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infection Control Program, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland. Hauptthemen laut MEDLINE: Citrobacter freundii, Enterobacteriaceae Infections, Drug Resistance, Multiple, Bacterial, Cross Infection. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federal Commission, Swiss Government Excellence, Joint Programming Initiative on Antimicrobial Resistance.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Citrobacter freundii is an emerging nosocomial pathogen, yet its transmission dynamics remain poorly characterized.

Methods

We conducted a retrospective genomic and epidemiological study to investigate the transmission chains of extended-spectrum beta-lactamase (ESBL) and carbapenemase-producing C. freundii collected at Geneva University Hospitals during a 6-year period (2017–2022). Whole-genome sequencing (WGS) using Nanopore long-read sequencing, MLST and plasmid typing, and resistome profiling were performed. Transmission events were defined based on genetic relatedness, plasmid similarity and patient trajectories.

Results

A total of 103 cases of ESBL and carbapenemase-producing C. freundii were identified, of which 79% were hospital-acquired, 72% were isolated from rectal swabs, and bacteremia occurred in 6 patients. Among 90 isolates available for WGS, 73% were confirmed as C. freundii, whereas the remaining belonged to other Citrobacter species. A high genetic diversity was observed among C. freundii sensu stricto, with 29 distinct sequence types, including predominant ST114, ST98, and ST22. We identified 10 clusters involving multiple Citrobacter species among 35 patients, with a median cluster duration of 103 weeks (IQR, 65–138). Transmission chain analysis revealed that 37% of patients were involved in putative clonal transmission and 21% in putative plasmid-mediated dissemination events, particularly in abdominal surgery, geriatrics and septic orthopedics, often involving C. freundii harboring blaCTX-M-15, blaOXA-48/CTX-M-14b, and blaOXA-181 on IncHI2-IncHI2A, IncM1, and IncX3 plasmids, respectively.

Conclusions

Our study highlights the role of C. freundii as a vector of both clonal and plasmid-mediated, nosocomial transmission of antimicrobial resistance. It emphasizes the need to include C. freundii in genomic and epidemiological surveillance to detect its silent spread.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Citrobacter freundiiEnterobacteriaceae InfectionsDrug Resistance, Multiple, BacterialCross InfectionHumansRetrospective StudiesTertiary Care CentersPlasmidsbeta-LactamasesFemaleMaleAgedMiddle AgedWhole Genome SequencingMultilocus Sequence TypingAnti-Bacterial AgentsMolecular EpidemiologySwitzerlandMicrobial Sensitivity TestsAged, 80 and over

Stichwörter der Autor:innen

Citrobacter freundiihospital acquiredmolecular epidemiologymultidrug resistanceplasmid transmission

Substanzen

beta-LactamasesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Infection Control Program, Geneva University Hospitals and Faculty of Medicine, WHO Collaborating Center, Geneva, Switzerland.
  • Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Infectious Diseases Division, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Division of Laboratory Medicine, Diagnostics Department, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

ORCID-Profile: Romain Martischang, Diego O Andrey, Stephan Harbarth

Förderung

  • Federal Commission
  • Swiss Government Excellence
  • Joint Programming Initiative on Antimicrobial Resistance
  • Schweizerischer National Fonds
  • Geneva University Hospitals
  • Research and Development Program

Zitieren

APA

Fonton, P., Sierra, R., Martischang, R., Nguyen, A., Cherkaoui, A., Andrey, D. O., & Harbarth, S. (2026). Epidemiological and Molecular Surveillance of Multiresistant Citrobacter freundii Complex in a Tertiary Care Hospital: A Retrospective Cohort Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag066

Vancouver

Fonton P, Sierra R, Martischang R, Nguyen A, Cherkaoui A, Andrey DO, et al. Epidemiological and Molecular Surveillance of Multiresistant Citrobacter freundii Complex in a Tertiary Care Hospital: A Retrospective Cohort Study. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag066

BibTeX
@article{Fonton2026,
  author = {Fonton, Pérince and Sierra, Roberto and Martischang, Romain and Nguyen, Aude and Cherkaoui, Abdessalam and Andrey, Diego O and Harbarth, Stephan},
  title = {Epidemiological and Molecular Surveillance of Multiresistant Citrobacter freundii Complex in a Tertiary Care Hospital: A Retrospective Cohort Study},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag066}
}
Kostenlos starten →